Publications:

Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer.

International Journal Of Molecular Sciences

Gaibar, María M; Galán, Miguel M; Romero-Lorca, Alicia A; Antón, Beatriz B; Malón, Diego D; Moreno, Amalia A; Fernández-Santander, Ana A; Novillo, Apolonia A

Publication Date: 2021-01-30

Variant appearance in text: rs2515462

PubMed Link: 33573134

Variant Present in the following documents:

• Main text
• ijms-22-01381.pdf

View BVdb publication page

Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Plos One

Makhoul, Issam I; Todorova, Valentina K VK; Siegel, Eric R ER; Erickson, Stephen W SW; Dhakal, Ishwori I; Raj, Vinay R VR; Lee, Jeannette Y JY; Orloff, Mohammed S MS; Griffin, Robert J RJ; Henry-Tillman, Ronda S RS; Klimberg, Suzanne S; Hutchins, Laura F LF; Kadlubar, Susan A SA

Publication Date: 2017

Variant appearance in text: rs2515462

PubMed Link: 28045923

Variant Present in the following documents:

• Main text
• pone.0168550.pdf

View BVdb publication page

Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery.

Plos One

Miaskowski, Christine C; Dodd, Marylin M; Paul, Steven M SM; West, Claudia C; Hamolsky, Deborah D; Abrams, Gary G; Cooper, Bruce A BA; Elboim, Charles C; Neuhaus, John J; Schmidt, Brian L BL; Smoot, Betty B; Aouizerat, Bradley E BE

Publication Date: 2013

Variant appearance in text: rs2515462

PubMed Link: 23613720

Variant Present in the following documents:

• Main text
• pone.0060164.pdf

View BVdb publication page